SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending as community members highlight its low market cap and potential for a breakout, with some comparing it to other trending tokens. Recent company updates on LinkedIn, particularly partnerships and the appchain model, are generating discussion, as are technical analyses suggesting bullish patterns. Some traders are expressing frustration with $AVT.X's inability to hold gains.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its strong chart setup, accumulation patterns, and potential for a breakout. The focus is on bullish technical indicators and growing momentum, with some suggesting it could be the next big community-driven crypto run. Overall, the community sentiment points towards anticipation for a significant upward move.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversations around DJT are currently focused on political division and the recent death of Charlie Kirk, with community members expressing strong opinions and engaging in heated debates. Some users are pointing fingers and assigning blame, while others are calling for unity and an end to political violence. The stock appears to be heavily influenced by broader socio-political narratives.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is surging, sparking excitement among its community who are eyeing potential gains and referencing a possible DOJE ETF. Discussions revolve around holding strategies, potential price targets, and whether this rally has enough momentum to reach previous highs. Some community members are suggesting that it is on track to reach $1 soon.

Ainalyzr is a versatile and engaging platform designed to provide crypto traders with advanced tools and a fun, interactive environment. Powered by the Ainalyzr token, it offers real-time analysis of Solana-based tokens, gamified trading tools, and a space for users to explore market trends and make data-driven decisions. Ainalyzr merges functionality and entertainment, appealing to both seasoned and novice traders.

AInalyzr

AInalyzr ($AINAL.X) is gaining attention as community members anticipate a potential breakout, citing bullish chart patterns and encouraging others to "stack" before it's too late. The crypto is being touted as a hidden gem with "rocket" potential, with many emphasizing the opportunity to get in early. Conversations suggest a strong sense of conviction among those already invested.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto "crow with knife" ($CAW.X) is trending, driven by community enthusiasm and its growing presence as a meme coin, particularly within the Cronos ($CRO.X) ecosystem.  Active discussions revolve around its unique branding and potential, with supporters emphasizing its community-driven nature and multichain functionality across $SOL.X, $CRO.X, and $ETH.X.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members highlight its charitable donations to dog shelters, with many expressing excitement about the project's potential and comparing it to other meme coins. The community is actively discussing the coin's mission and anticipating further gains, viewing it as a 'dog-coin' with a cause. There is also increased interest around 'what is UpDog?'

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community rallies around a potential breakout, fueled by bullish chart patterns and significant accumulation by key players. Many are pointing to $AINAL.X as the next big opportunity within the Solana ecosystem, urging others to get in early before a potential surge. The overall sentiment suggests strong momentum and anticipation for further gains in the near future.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as community members discuss its potential for growth and utility compared to Bitcoin, particularly highlighting faster transaction times and lower fees. Some analysts anticipate a breakout, while others point to accumulation patterns and potential ETF catalysts. Discussions include price targets and whether it can outperform Bitcoin as market focus shifts from speculation to utility.

Trump For President

Conversation around TRUMP.X seems to be driven by speculation around an upcoming meme coin launch and its potential impact, with some users drawing comparisons to previous Trump-related coins. There is also discussion around political implications and events, with community members expressing strong opinions. The community appears to be weighing potential gains against the inherent risks associated with politically themed meme coins.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mineralys Therapeutics Inc. (123% jump in watchers)The clinical-stage biopharmaceutical company saw the highest jump in retail interest after reporting positive topline data from its Phase 3 and Phase 2 trials for lorundrostat in treating uncontrolled hypertension (uHTN) and resistant hypertension (rHTN). Both trials met their primary efficacy endpoints, showing statistically significant blood pressure reductions.&nbsp;The company also announced a $250 million underwritten public offering to fund lorundrostat’s development and pre-commercialization efforts.Mineralys stock is up over 15% year-to-date (YTD).Tenaya Therapeutics Inc. (11% jump in watchers)Tenaya saw increased attention after reporting stronger-than-expected fourth-quarter earnings and highlighting upcoming clinical data readouts for its gene therapy programs targeting cardiomyopathies.&nbsp;CEO Faraz Ali noted continued progress in the TN-201 MyPEAK-1 and TN-401 RIDGE-1 trials.&nbsp;Tenaya’s stock remains down over 53% YTD.SpringWorks Therapeutics Inc. (10% jump in watchers)SpringWorks gained traction amid ongoing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/swtx-sees-biggest-weekly-biotech-jump-in-stocktwits-following/cheUZARRbb2">speculation</a> about a potential buyout by Merck KGaA. While Merck confirmed advanced merger discussions in its annual report, it stopped short of announcing a deal, leaving traders searching for clues. The company’s withdrawal from a Barclays healthcare conference further fueled speculation.&nbsp;SpringWorks stock is up more than 40% YTD.COSCIENS Biopharma Inc. (9% jump in watchers)COSCIENS initiated a Phase 2a clinical efficacy trial for its avenanthramides product, which is being explored for its anti-inflammatory properties. The trial, dubbed the AvenActive study, will assess safety and efficacy in two dosage arms.&nbsp;COSCIENS stock has gained over 20% YTD.Metagenomi Inc. (7% jump in watchers)Metagenomi published new research in Nature Communications on its novel CAST gene editing system, which enables precise, programmable integration of large gene cargoes. The technology could have major implications for treating genetic diseases like cystic fibrosis and Duchenne Muscular Dystrophy.&nbsp;Metagenomi stock is down more than 46% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.  

Equity

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.  


Strong Buy on Tenaya Therapeutics: Regulatory Milestones and Financial Strategy Driving Growth

William Blair analyst Sami Corwin has maintained their bullish stance on TNYA stock, giving a Buy rating today. Sami Corwin has given his Buy ratin...

Buy Rating on Tenaya Therapeutics: Promising Clinical Trials and Solid Financial Position

TD Cowen analyst Ritu Baral has maintained their bullish stance on TNYA stock, giving a Buy rating on July 26. Ritu Baral has given his Buy rating...

Tenaya Therapeutics (NASDAQ:TNYA) PT Lowered to $18.00 at Canaccord Genuity Group

Tenaya Therapeutics (NASDAQ:TNYA  Free Report) had its price target lowered by Canaccord Genuity Group from $19.00 to $18.00 in a research note issued to investors on Wednesday, Benzinga...

Tenaya Therapeutics (NASDAQ:TNYA) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA  Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vera Therapeutics (VERA Research Report), Tyra Bioscience (TYRA...

Tenaya Therapeutics (NASDAQ:TNYA) Given New $18.00 Price Target at Canaccord Genuity Group

Tenaya Therapeutics (NASDAQ:TNYA  Free Report) had its price target lowered by Canaccord Genuity Group from $19.00 to $18.00 in a research report released on Wednesday morning, Benzinga...

Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results

Biotech Firm Prepares for Clinical Trials with Extended Cash RunwayRelated Stocks: TNYA...

Commit To Buy Tenaya Therapeutics At $2.50, Earn 17.9% Annualized Using Options

Investors eyeing a purchase of Tenaya Therapeutics Inc (TNYA) stock, but tentative about paying the going market price of 4.53/share, might benefit from considering selling puts among the...

Analysts' Top Healthcare Picks: Inventiva (IVA), Tenaya Therapeutics (TNYA)

Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inventiva (IVA Research Report) and Tenaya Therapeutics...

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Current Price	$1.20
Prev Close	$1.28
Open	$1.28
Dividend Yield	0.00%
50-Day Moving Average	$0.912
Beta	1.96
Avg. Volume	3.92M
PE Ratio	-1.33

52-Week High	$4.01
52-Week Low	$0.36
Market Capitalization	$208.61M
EPS (Annual)	-$1.31
Price to Book	2.09
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

TNYA
Tenaya Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNYA News

TNYA Tenaya Therapeutics Inc